Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 USD | -1.95% | +8.26% | +6.87% |
Apr. 04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
Feb. 29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 36.23M | |
+24.17% | 562B | |
-6.13% | 358B | |
+19.79% | 322B | |
+7.70% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.76% | 149B | |
-6.19% | 146B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics : Barclays Adjusts Price Target for VYNE Therapeutics to $15 From $12, Maintains Overweight Rating